AltheaDx to Offer New Test for Clinical Study of Cancer Patients
DxS Ltd has announced an agreement with AltheaDx, Inc, to provide study centers in the US with access to DxS K-RAS mutation detection assays.
Read MorePosted by Clinical Lab Products | Nov 5, 2008 | Cancer, Miscellaneous |
DxS Ltd has announced an agreement with AltheaDx, Inc, to provide study centers in the US with access to DxS K-RAS mutation detection assays.
Read MorePosted by Clinical Lab Products | Oct 15, 2008 | Cancer, Miscellaneous |
The intellectual property (IP) system in the US must be transformed if it is to foster biotechnological advances, national and international IP and biotech leaders said today.
Read MorePosted by Clinical Lab Products | Oct 13, 2008 | Cancer, Miscellaneous, Osteoporosis |
Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Childrens Center.
Read MorePosted by Clinical Lab Products | Oct 7, 2008 | Cancer, Miscellaneous |
The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologiessuch as HPV testing and HPV vaccinesthat are helping to eradicate cervical cancer globally.
Read MorePosted by Clinical Lab Products | Oct 6, 2008 | Molecular Diagnostics |
Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News.
Read More